{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.75","value":"69.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"207"}],"units":"Participants"}],"title":"Heart Rate: Baseline (actual)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.09","value":"65.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"202"}],"units":"Participants"}],"title":"Heart Rate: Post-dosing (actual)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"7.93","value":"-4.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"202"}],"units":"Participants"}],"title":"Heart Rate: Change from Baseline"}],"denoms":[{"counts":[{"groupId":"OG000","value":"208"}],"units":"Participants"}],"description":"The recorded values and their respective changes from the pre-dose values will be summarized using descriptive statistics.","dispersionType":"Standard Deviation","groups":[{"description":"Participants with suspected recurrence of prostate cancer and negative or equivocal findings per institutional standard of care conventional imaging were enrolled to receive a single dose of 9 mCi (333 MBq) 18F-DCFPyL injection followed by a single PET/CT scan acquired 1 to 2 hours post-dosing.","id":"OG000","title":"18F-DCFPyL Injection"}],"paramType":"MEAN","populationDescription":"The Safety Set includes all participants who received any amount of 18F-DCFPyL.","reportingStatus":"POSTED","timeFrame":"Measured at 2 intervals on the day of dosing; the first interval prior to receiving the 18F-DCFPyL dose and the second interval within 60 to 120 minutes after dosing.","title":"The Change From Pre- to Post- 18F-DCFPyL Dosing in Heart Rate (Safety Outcome Measure)","type":"SECONDARY","unitOfMeasure":"bpm"}